Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

NCT01639352 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Lynn Feun